Selumetinib
Selumetinib ATC Code L01EE04 : Antineoplastic and immunomodulating agents - Antineoplastic drugs - Protein kinase inhibitors - Mitogen-activated protein kinase (MEK) inhibitors - Selumetinib
Routes | Oral |
---|---|
FDA Approval Date | 2020-04-10 |
Molecular Formula | C17H15BrClFN4O3 |
Molecular Weight | 457.68 g/mol |
CAS Number | 606143-52-6 |
Brand names | Koselugo |